BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
NTRA | Natera Inc | Healthcare | Diagnostics & Research | 6.03% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 5.08% |
GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 4.71% |
MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 4.38% |
INSM | Insmed Inc | Healthcare | Biotechnology | 4.10% |
207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 3.81% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.49% |
KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.36% |
CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 3.06% |
AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 3.01% |
BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 2.77% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.76% |
UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.72% |
BNTX | BioNTech SE | Healthcare | Biotechnology | 2.51% |
CDNS | Cadence Design Systems Inc | Technology | Software - Application | 2.42% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.26% |
TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 2.15% |
LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.09% |
ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 2.03% |
TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 1.91% |